Co-creation of patient engagement quality guidance for medicines development: an international multistakeholder initiative

Deane, Katherine ORCID:, Delbecque, Laure, Gorbenko, Oleksandr, Hamoir, Anne Marie, Hoos, Anton, Nafria, Begonya, Pakarinen, Chi, Sargeant, Ify, Richards, Dawn P, Skovlund, Soren Eik and Brooke, Nicholas (2019) Co-creation of patient engagement quality guidance for medicines development: an international multistakeholder initiative. BMJ Innovations, 5 (1). pp. 43-55. ISSN 2055-8074

[thumbnail of PEQG_BMJ Innov_2019]
PDF (PEQG_BMJ Innov_2019) - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (1MB) | Preview


Introduction: Meaningful patient engagement (PE) can enhance medicines’ development. However, the current PE landscape is fragmentary and lacking comprehensive guidance. Methods: We systematically searched for PE initiatives (SYNaPsE database/publications). Multistakeholder groups integrated these with their own PE expertise to co-create draft PE Quality Guidance which was evaluated by public consultation. Projects: exemplifying good PE practice were identified and assessed against PE Quality Criteria to create a Book of Good Practices (BOGP). Results: Seventy-six participants from 51 organisations participated in nine multistakeholder meetings (2016–2018). A shortlist of 20relevant PE initiatives (from 170 screened) were identified. The co-created INVOLVE guidelines provided the main framework for PE Quality Guidance and was enriched with the analysis of the PE initiatives and the PE expertise of stakeholders. Seven key PE Quality Criteria were identified. Public consultation yielded 67 responses from diverse backgrounds. The PE Quality Guidance was agreed to be useful for achieving quality PE in practice, understandable, easy to use, and comprehensive. Overall, eight initiatives from the shortlist and from meeting participants were selected for inclusion in the BOGP based on demonstration of PE Quality Criteria and willingness of initiative owners to collaborate. Discussion: The PE Quality Guidance and BOGP are practical resources which will be continually updated in response to user feedback. They are not prescriptive, but rather based on core principles, which can be applied according to the unique needs of each interaction and initiative. Implementation of the guidance will facilitate improved and systematic PE across the medicines’ development lifecycle.

Item Type: Article
Uncontrolled Keywords: patient engagement,clinical trials
Faculty \ School: Faculty of Medicine and Health Sciences > School of Health Sciences
Depositing User: LivePure Connector
Date Deposited: 04 Mar 2019 09:30
Last Modified: 21 Oct 2022 21:40
DOI: 10.1136/bmjinnov-2018-000317

Actions (login required)

View Item View Item